I think there's an opportunity for us to go through the regulatory collaboration for biotech and address that issue through that. If you look at the timelines, we're almost a year slower than the FDA, and I think the number is around 267 days slower than the EU in approving products. So that's step one.
On February 3rd, 2014. See this statement in context.